Colorectal Cancer Screening and State Health Insurance Mandates
Colorectal cancer (CRC) is the third most deadly cancer in the USA. CRC screening is the most effective way to prevent CRC death, but compliance with recommended screenings is very low. In this study, we investigate whether CRC screening behavior changed under state mandated private insurance covera...
Gespeichert in:
Veröffentlicht in: | Health economics 2016-02, Vol.25 (2), p.178-191 |
---|---|
Hauptverfasser: | , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 191 |
---|---|
container_issue | 2 |
container_start_page | 178 |
container_title | Health economics |
container_volume | 25 |
creator | Hamman, Mary K. Kapinos, Kandice A. |
description | Colorectal cancer (CRC) is the third most deadly cancer in the USA. CRC screening is the most effective way to prevent CRC death, but compliance with recommended screenings is very low. In this study, we investigate whether CRC screening behavior changed under state mandated private insurance coverage of CRC screening in a sample of insured adults from the 1997 to 2008 Behavioral Risk Factor Surveillance Survey (BRFSS). We present difference‐in‐difference‐in‐differences (DDD) estimates that compare insured individuals age 51 to 64 to Medicare age‐eligible individuals (ages 66 to 75) in mandate and non‐mandate states over time. Our DDD estimates suggest endoscopic screening among men increased by 2 to 3 percentage points under mandated coverage among 51 to 64 year olds relative to their Medicare age‐eligible counterparts. We find no clear evidence of changes in screening behavior among women. DD estimates suggest no evidence of a mandate effect on either type of CRC screening for men or women. Copyright © 2014 John Wiley & Sons, Ltd. |
doi_str_mv | 10.1002/hec.3132 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1760875576</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1760875576</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4932-efc92f6bcab1367252e2dc5d6a4d5fdf73268e2b9535bb041e14c5affea94e513</originalsourceid><addsrcrecordid>eNp1kL1OwzAURi0EoqUg8QQoI0uKf-K4mRCE0la0MATEaDnONQ2kSbETQd-eRC1lYrpX-o7OcBA6J3hIMKZXS9BDRhg9QH2Co8gnmOPD7ufCjyjDPXTi3DvG7YbDY9SjnFMSsFEfXcdVUVnQtSq8WJUarJdoC1Dm5ZunysxLalWDNwVV1EtvVrrGdpS3aLd2cKfoyKjCwdnuDtDL_fg5nvrzp8ksvpn7OogY9cHoiJow1SolLBSUU6CZ5lmogoybzAhGwxHQNOKMpykOCJBAc2UMqCgATtgAXW69a1t9NuBqucqdhqJQJVSNk0SEeCQ4F-Efqm3lnAUj1zZfKbuRBMsul2xzyS5Xi17srE26gmwP_vZpAX8LfOUFbP4Vyek43gl3fO5q-N7zyn7IUDDB5evjRC4eEnJ3K25lwn4ANemB1A</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1760875576</pqid></control><display><type>article</type><title>Colorectal Cancer Screening and State Health Insurance Mandates</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Hamman, Mary K. ; Kapinos, Kandice A.</creator><creatorcontrib>Hamman, Mary K. ; Kapinos, Kandice A.</creatorcontrib><description>Colorectal cancer (CRC) is the third most deadly cancer in the USA. CRC screening is the most effective way to prevent CRC death, but compliance with recommended screenings is very low. In this study, we investigate whether CRC screening behavior changed under state mandated private insurance coverage of CRC screening in a sample of insured adults from the 1997 to 2008 Behavioral Risk Factor Surveillance Survey (BRFSS). We present difference‐in‐difference‐in‐differences (DDD) estimates that compare insured individuals age 51 to 64 to Medicare age‐eligible individuals (ages 66 to 75) in mandate and non‐mandate states over time. Our DDD estimates suggest endoscopic screening among men increased by 2 to 3 percentage points under mandated coverage among 51 to 64 year olds relative to their Medicare age‐eligible counterparts. We find no clear evidence of changes in screening behavior among women. DD estimates suggest no evidence of a mandate effect on either type of CRC screening for men or women. Copyright © 2014 John Wiley & Sons, Ltd.</description><identifier>ISSN: 1057-9230</identifier><identifier>EISSN: 1099-1050</identifier><identifier>DOI: 10.1002/hec.3132</identifier><identifier>PMID: 25521438</identifier><language>eng</language><publisher>England: Blackwell Publishing Ltd</publisher><subject>cancer screening ; Colorectal Neoplasms - diagnosis ; Colorectal Neoplasms - prevention & control ; Early Detection of Cancer - methods ; Female ; Government Regulation ; health insurance mandates ; Humans ; Insurance Coverage - legislation & jurisprudence ; Insurance, Health - legislation & jurisprudence ; Male ; Mass Screening - legislation & jurisprudence ; Mass Screening - statistics & numerical data ; Middle Aged ; Models, Statistical ; Surveys and Questionnaires ; United States</subject><ispartof>Health economics, 2016-02, Vol.25 (2), p.178-191</ispartof><rights>Copyright © 2014 John Wiley & Sons, Ltd.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4932-efc92f6bcab1367252e2dc5d6a4d5fdf73268e2b9535bb041e14c5affea94e513</citedby><cites>FETCH-LOGICAL-c4932-efc92f6bcab1367252e2dc5d6a4d5fdf73268e2b9535bb041e14c5affea94e513</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fhec.3132$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fhec.3132$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,777,781,1412,27905,27906,45555,45556</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25521438$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hamman, Mary K.</creatorcontrib><creatorcontrib>Kapinos, Kandice A.</creatorcontrib><title>Colorectal Cancer Screening and State Health Insurance Mandates</title><title>Health economics</title><addtitle>Health Econ</addtitle><description>Colorectal cancer (CRC) is the third most deadly cancer in the USA. CRC screening is the most effective way to prevent CRC death, but compliance with recommended screenings is very low. In this study, we investigate whether CRC screening behavior changed under state mandated private insurance coverage of CRC screening in a sample of insured adults from the 1997 to 2008 Behavioral Risk Factor Surveillance Survey (BRFSS). We present difference‐in‐difference‐in‐differences (DDD) estimates that compare insured individuals age 51 to 64 to Medicare age‐eligible individuals (ages 66 to 75) in mandate and non‐mandate states over time. Our DDD estimates suggest endoscopic screening among men increased by 2 to 3 percentage points under mandated coverage among 51 to 64 year olds relative to their Medicare age‐eligible counterparts. We find no clear evidence of changes in screening behavior among women. DD estimates suggest no evidence of a mandate effect on either type of CRC screening for men or women. Copyright © 2014 John Wiley & Sons, Ltd.</description><subject>cancer screening</subject><subject>Colorectal Neoplasms - diagnosis</subject><subject>Colorectal Neoplasms - prevention & control</subject><subject>Early Detection of Cancer - methods</subject><subject>Female</subject><subject>Government Regulation</subject><subject>health insurance mandates</subject><subject>Humans</subject><subject>Insurance Coverage - legislation & jurisprudence</subject><subject>Insurance, Health - legislation & jurisprudence</subject><subject>Male</subject><subject>Mass Screening - legislation & jurisprudence</subject><subject>Mass Screening - statistics & numerical data</subject><subject>Middle Aged</subject><subject>Models, Statistical</subject><subject>Surveys and Questionnaires</subject><subject>United States</subject><issn>1057-9230</issn><issn>1099-1050</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kL1OwzAURi0EoqUg8QQoI0uKf-K4mRCE0la0MATEaDnONQ2kSbETQd-eRC1lYrpX-o7OcBA6J3hIMKZXS9BDRhg9QH2Co8gnmOPD7ufCjyjDPXTi3DvG7YbDY9SjnFMSsFEfXcdVUVnQtSq8WJUarJdoC1Dm5ZunysxLalWDNwVV1EtvVrrGdpS3aLd2cKfoyKjCwdnuDtDL_fg5nvrzp8ksvpn7OogY9cHoiJow1SolLBSUU6CZ5lmogoybzAhGwxHQNOKMpykOCJBAc2UMqCgATtgAXW69a1t9NuBqucqdhqJQJVSNk0SEeCQ4F-Efqm3lnAUj1zZfKbuRBMsul2xzyS5Xi17srE26gmwP_vZpAX8LfOUFbP4Vyek43gl3fO5q-N7zyn7IUDDB5evjRC4eEnJ3K25lwn4ANemB1A</recordid><startdate>201602</startdate><enddate>201602</enddate><creator>Hamman, Mary K.</creator><creator>Kapinos, Kandice A.</creator><general>Blackwell Publishing Ltd</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201602</creationdate><title>Colorectal Cancer Screening and State Health Insurance Mandates</title><author>Hamman, Mary K. ; Kapinos, Kandice A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4932-efc92f6bcab1367252e2dc5d6a4d5fdf73268e2b9535bb041e14c5affea94e513</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>cancer screening</topic><topic>Colorectal Neoplasms - diagnosis</topic><topic>Colorectal Neoplasms - prevention & control</topic><topic>Early Detection of Cancer - methods</topic><topic>Female</topic><topic>Government Regulation</topic><topic>health insurance mandates</topic><topic>Humans</topic><topic>Insurance Coverage - legislation & jurisprudence</topic><topic>Insurance, Health - legislation & jurisprudence</topic><topic>Male</topic><topic>Mass Screening - legislation & jurisprudence</topic><topic>Mass Screening - statistics & numerical data</topic><topic>Middle Aged</topic><topic>Models, Statistical</topic><topic>Surveys and Questionnaires</topic><topic>United States</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hamman, Mary K.</creatorcontrib><creatorcontrib>Kapinos, Kandice A.</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Health economics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hamman, Mary K.</au><au>Kapinos, Kandice A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Colorectal Cancer Screening and State Health Insurance Mandates</atitle><jtitle>Health economics</jtitle><addtitle>Health Econ</addtitle><date>2016-02</date><risdate>2016</risdate><volume>25</volume><issue>2</issue><spage>178</spage><epage>191</epage><pages>178-191</pages><issn>1057-9230</issn><eissn>1099-1050</eissn><abstract>Colorectal cancer (CRC) is the third most deadly cancer in the USA. CRC screening is the most effective way to prevent CRC death, but compliance with recommended screenings is very low. In this study, we investigate whether CRC screening behavior changed under state mandated private insurance coverage of CRC screening in a sample of insured adults from the 1997 to 2008 Behavioral Risk Factor Surveillance Survey (BRFSS). We present difference‐in‐difference‐in‐differences (DDD) estimates that compare insured individuals age 51 to 64 to Medicare age‐eligible individuals (ages 66 to 75) in mandate and non‐mandate states over time. Our DDD estimates suggest endoscopic screening among men increased by 2 to 3 percentage points under mandated coverage among 51 to 64 year olds relative to their Medicare age‐eligible counterparts. We find no clear evidence of changes in screening behavior among women. DD estimates suggest no evidence of a mandate effect on either type of CRC screening for men or women. Copyright © 2014 John Wiley & Sons, Ltd.</abstract><cop>England</cop><pub>Blackwell Publishing Ltd</pub><pmid>25521438</pmid><doi>10.1002/hec.3132</doi><tpages>14</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1057-9230 |
ispartof | Health economics, 2016-02, Vol.25 (2), p.178-191 |
issn | 1057-9230 1099-1050 |
language | eng |
recordid | cdi_proquest_miscellaneous_1760875576 |
source | MEDLINE; Wiley Online Library Journals Frontfile Complete |
subjects | cancer screening Colorectal Neoplasms - diagnosis Colorectal Neoplasms - prevention & control Early Detection of Cancer - methods Female Government Regulation health insurance mandates Humans Insurance Coverage - legislation & jurisprudence Insurance, Health - legislation & jurisprudence Male Mass Screening - legislation & jurisprudence Mass Screening - statistics & numerical data Middle Aged Models, Statistical Surveys and Questionnaires United States |
title | Colorectal Cancer Screening and State Health Insurance Mandates |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-18T12%3A31%3A26IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Colorectal%20Cancer%20Screening%20and%20State%20Health%20Insurance%20Mandates&rft.jtitle=Health%20economics&rft.au=Hamman,%20Mary%20K.&rft.date=2016-02&rft.volume=25&rft.issue=2&rft.spage=178&rft.epage=191&rft.pages=178-191&rft.issn=1057-9230&rft.eissn=1099-1050&rft_id=info:doi/10.1002/hec.3132&rft_dat=%3Cproquest_cross%3E1760875576%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1760875576&rft_id=info:pmid/25521438&rfr_iscdi=true |